New European guidelines for the management of dyslipidaemia in cardiovascular prevention;Les nouvelles recommandations Européennes pour le traitement des dyslipidémies en prévention cardiovasculaire

Revue Medicale de Liege

Volumn 67, Issue 3, 2012, Pages 118-127

  Descamps, O S ^a   De Backer, G ^b,f   Annemans, L ^c   Muls, E ^d   Scheen, A J ^e   Carpentier, Y ^f   Descamps, O ^f   Ducobu, J ^f   Herman, A ^f   Langlois, M ^f   Radermecker, R ^f   Rietzschel, E ^f  

^a Hospital de Jolimont   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f NONE

Author keywords

Cardiovascular disease; Cardiovascular risk; Cholesterol; Diabetes; Prevention; Therapeutic target; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; KIDNEY FAILURE; PRACTICE GUIDELINE; PRIMARY PREVENTION; REVIEW;

ALGORITHMS; BELGIUM; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; EUROPE; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; MALE; PRACTICE GUIDELINES AS TOPIC; REFERENCE VALUES; RESEARCH DESIGN; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84858851418     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. De Backer G, De Bacquer D, Brohet C, et al.; Groupe de Travail Belge de Prévention des Maladies Cardiovasculaires. - Recommandations relatives à la prévention des maladies cardio-vasculaires en pratique clinique. Belgian Working Group on Prevention of Cardiovascular Diseases. Rev Med Liege, 2005, 60, 163-172. (Pubitemid 40558691)
2. Scheen AJ, Radermecker R, De Flines J, Ducobu J. - Actualités thérapeutiques en lipidologje. Rev Med Liège, 2007, 62, 324-328.
3. Descamps OS, Tenoutasse S, Stephenne X, et al. - Management of familial hypercholesterolemia in children and young adults : consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis, 2011, 218, 272-280.
4. Reiner Z, Catapano AL, De Backer G, et al. - ESC/EAS Guidelines for the management of dyslipidaemias : the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). European Association for Cardiovascular Prevention & Rehabilitation. Eur Heart J, 2011, 32, 1769-1818.
5. Graham I, Atar D, Borch-Johnsen K, et al. - European guidelines on cardiovascular disease prevention in clinical practice. Fourth joint task force of the European society on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil, 2007, 14 (Suppl 2), S1-S112.
6. H. Dereppe, C. Laruelle, G. De Backer, et al. - Recommandations relatives à la prévention des maladies cardiovasculaires en pratique clinique. Groupe de travail belge de prévention des maladies cardiovasculaires Guidelines on cardiovascular disease prevention in clinical practice. Belgian Working Group on Cardiovascular Prevention and Rehabilitation. Rev Med Brux, 2009, 30, 37-46.
7. Descamps OS. - Nouvelles recommandations 2007 en matière de prévention cardiovasculaire. Aspects lipidiques*. Louvain Medical, 2007, 126, S196-S206.
8. De Bacquer D, De Backer G. - Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality. Int J Cardiol, 2010, 143, 385-390.
9. Cooney MT, Dudina A, De Bacquer D, Fitzgerald A, et al. - How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators. Eur J Cardiovasc Prev Rehabil, 2009, 16, 304-314.
10. Descamps O, Cooney MT, Graham I, De Backer G. - A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE. Atherosclerosis, 2012, Submitted.
11. Descamps O, Scheen AJ, De Backer G, et al. - Comment je traite ... une dyslipidémie en fonction du profil de risque cardio-vasculaire. Rev Med Liège, 2012, 67, sous presse.
12. Greving JP, Visseren FL, de Wit GA, Algra A. - Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis. BMJ, 2011, 342, d1672.
13. Brunner E, Cohen D, Toon L. - Cost effectiveness of cardiovascular disease prevention strategies : a perspective on EU food based dietary guidelines. Public Health Nutr, 2001, 4, 711-715. (Pubitemid 32524592)
14. Nicholls SJ, Brandrup-Wognsen G, Palmer M, Barter PJ. - Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER). Am J Cardiol, 2010, 105, 69-76.
15. Descamps O. - Prévention cardiovasculaire. Quelle statine et à quelle dose ? Louvain Méd, 2011, 130, S23-30.
16. Ramjee V, Sperling LS, Jacobson TA. - Non-high-density lipoprotein cholesterol versus apolipoprotein B in cardiovascular risk stratification: do the math. J Am Coll Cardiol, 2011, 26, 457-463.
17. Ducobu J, Scheen A, Van Gaal L, et al. - Belgian expert opinion : how to reduce the residual risk in atherogenic dyslipidaemic patients : place of fibrates. Acta Cardiol, 2008, 63, 235-248. (Pubitemid 351548712)
18. Descamps OS, Hermans MP, Persu A. - Renaissance de la niacine sous une nouvelle forme galénique, le TREDAPTIVE. Louvain Méd, 2009, 128, 308-318.
19. Radermecker RP, Scheen AJ. - Comment optimaliser le traitement hypolipidémiant: ne pas oublier la problématique du défaut d'observance. Rev Med Liège, 2010, 65, 311-317.
20. Kotseva K, Wood D, De Backer G, et al. - Cardiovascular revention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet, 2009, 373, 929-940.
21. Kotseva K, Wood D, De Backer G, et al. - EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil, 2010, 17, 530-540.
22. Banegas JR, López-García E, Dallongeville J, et al. - Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe : the EURIKA study. Eur Heart J, 2011, 32, 2143-2152
23. De Smedt D, Annemans L, De Backer G, et al. - EUROASPIRE III : modelling the clinical and cost-effectiveness of optimizing cardiovascular prevention in patients with established coronary heart disease in Europe (abstract). Presentation at the European Congress of Cardiology, 2011 (Paris, France, August 27-31, 2011), session number 711002.